<html>
<head>PUBMED IDs for LMTK3</head>
<body bgcolor='#C5F0F2'><h1>LMTK3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19433805/'>RNAi screen for rapid therapeutic target identification in leukemia patients.</a> June 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21602804/'>Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.</a> August 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22869149/'>LMTK3 is implicated in endocrine resistance via multiple signaling pathways.</a> September 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24050776/'>MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line.</a> January 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24939894/'>The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.</a> February 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24939888/'>Evidence of extensive DNA transfer between bacteroidales species within the human gut.</a> January 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25163465/'>High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.</a> December 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25200445/'>Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer.</a> July 25  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25287073/'>Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.</a> February 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26212333/'>LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer.</a> May 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26739063/'>LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.</a> July 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28260052/'>LMTK3 knockdown retards cell growth and invasion and promotes apoptosis in thyroid cancer.</a> March 6  2017<br></body></html>
